Nestle recalls DiGiorno pizza nationwide following consumer complaint

Nestle USA Inc. of Schaumburg, IL, is recalling almost 14 tons of frozen DiGiorno Crispy Pan Crust pepperoni pizza because of misbranding and undeclared allergens, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The product contains textured soy protein, a known allergen, which is not declared on the product label.

The frozen pepperoni pizza product carton may actually contain frozen three meat pizza, which contains textured soy protein. The pizza products were produced on June 30, 2021. The best-buy date is March of 2022.

“FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase,” according to the recall announcement.

Consumers view the labels here and use the following information to determine whether they have the recalled pizza in their homes.

  • 26-oz. carton containing “DIGIORNO PEPPERONI CRISPY PAN CRUST” with lot code 1181510721 and “Best Buy” date of MAR2022 on the label.

The products subject to recall bear establishment number “EST. 1682A” printed inside the USDA mark of inspection. Establishment 1682A is Nation Pizza Products Limited, which is owned by Nestle USA, Inc. These items were shipped to retail locations and distribution centers nationwide.

 The problem was discovered after the firm received a consumer complaint that a three meat pizza was in a carton labeled as pepperoni pizza.

There have been no confirmed reports of adverse allergic reactions related to consumption of the pizza. Anyone concerned about an injury or illness should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution lists will be posted on the FSIS website at www.fsis.usda.gov/recalls.

Consumers with questions about the recall can contact Bonita Cleveland, Consumer Services Manager at Nestle USA, at 800-681-1676 or bonita.cleveland@us.nestle.com.

(To sign up for a free subscription to Food Safety News, click here.)

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Two years on, we could be entering a new phase in the pandemic with plausible hope for stabilization, yet too early to drop our guard thumbnail

Two years on, we could be entering a new phase in the pandemic with plausible hope for stabilization, yet too early to drop our guard

Statement by Dr Hans Henri P. Kluge, WHO Regional Director for EuropeCopenhagen, 24 January 2022As we mark 2 years of the COVID-19 pandemic in Europe and central Asia, we are entering a new phase, driven by the highly transmissible Omicron variant sweeping the Region, from west to east.Omicron is displacing Delta with unprecedented speed. Less…
Read More
HBD Joe Root: All-time England great turns 33 thumbnail

HBD Joe Root: All-time England great turns 33

England's all-time cricket great Joe Root is celebrating his 33rd birthday on December 30th, 2023 Born on December 30th, 1990, in Sheffield, South Yorkshire, England, Root has become a central figure in English cricketRoot's career is highlighted by numerous achievements, including being named the ICC Men's Test Cricketer of the Year and the Wisden Leading
Read More
France's Sanofi halts work on anti-Covid vaccine thumbnail

France’s Sanofi halts work on anti-Covid vaccine

Transmission electron microscope image of SARS-CoV-2, the virus that causes COVID-19, emerging from human cells. Credit: NIAID French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot. The company said it would focus instead on…
Read More
Index Of News
Total
0
Share